Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 283-291

  Feng, Zhengyu ^a   Barletta, Raúl G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALANINE LIGASE; ALANINE RACEMASE; CYCLOSERINE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; AUTORADIOGRAPHY; BACTERICIDAL ACTIVITY; DNA LIBRARY; DRUG SENSITIVITY; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; STEADY STATE; STRAIN DIFFERENCE;

EID: 0037228454     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.283-291.2003     Document Type: Article

References (37)

1. Bashyam, M. D., and A. Tyagi. 1994. An efficient and high-yielding method for isolation of RNA from mycobacteria. BioTechniques 17:834-836.
2. Belanger, A. E., and J. M. lnamine. 2000. Genetics of cell wall biosynthesis, p. 191-202. In G. F. Hatfull and W. R. J. Jacobs (ed.), Molecular genetics of mycobacteria. ASM Press, Washington, D.C.
3. Belanger, A. E., J. C. Porter, and G. F. Hatfull. 2000. Genetic analysis of peptidoglycan biosynthesis in mycobacteria: characterization of a ddlA mutant of Mycobacterium smegmatis. J. Bacteriol. 182:6854-6856.
4. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64:29-63.
5. Caceres, N. E., N. B. Harris, J. F. Wellehan, Z. Feng, V. Kapur, and R. G. Barletta. 1997. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. J. Bacteriol. 179:5046-5055.
6. Chacon, O., Z. Feng, N. B. Harris, N. E. Caceres, L. G. Adams, and R. G. Barletta. 2002. Mycobacterium Smegmatis D-alanine racemase mutants are not dependent on D-alanine for growth. Antimicrob. Agents Chemother. 46:47-54.
7. Connell, N. D., E. Medina-Acosta, W. R. McMaster, B. R. Bloom, and D. G. Russell. 1993. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. USA 90:11473-11477.
8. David, H. L. 1971. Resistance to D-cycloserine in the tubercle bacilli: mutation rate and transport of alanine in parental cells and drug-resistant mutants. Appl. Microbiol. 21:888-892.
9. David, H. L., K. Takayama, and D. S. Goldman. 1969. Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine. Am. Rev. Respir. Dis. 100:579-581.
10. David, S. 2001. Synergic activity of D-cycloserine and ss-chloro-D-alanine against Mycobacterium tuberculosis. J. Antimicrob. Chemother. 47:203-206.
11. Davis, L. G., W. M. Kuehl, and J. F. Battey. 1994. Basic methods in molecular biology, 2nd ed. Appleton & Lange, Norwalk, Conn.
12. Dutka-Malen, S., C. Molinas, M. Arthur, and P. Courvalin. 1992. Sequence of the vanc gene of Enterococuts gallinarum BM4174 encoding a D-alanine: D-alanine ligase-related protein necessary for vancomycin resistance. Gene 112:53-58.
13. Farmer, P. 2001. DOTS and DOTS-plus: not the only answer. Ann. N. Y. Acad. Sci. 953:165-184.
14. Foley-Thomas, E. M., D. L. Whipple, L. E. Bermudez, and R. G. Barletta. 1995. Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis. Microbiology 141:1173-1181.
15. Kaufman, D. S., and W. F. Manley. 1998. A new procedure for determining enantiomeric (D/L) amino acid ratios in fossils using reverse phase liquid chromatography. Quat. Sci. Rev. 17:987-1000.
16. Lambert, M. P., and F. C. Neuhaus. 1972. Mechanism of D-Cycloserine action: alanine racemase from Escherichia coli W. J. Bacteriol. 110:978-987.
17. Manning, J. M., N. E. Merrifield, W. M. Jones, and E. C. Gotschlich. 1974. Inhibition of bacterial growth by beta-chloro-D-alanine. Proc. Natl. Acad. Sci. USA 71:417-421.
18. Marshall, C. G., and G. D. Wright. 1998. DdlN from vancomycin-producing Amycolatopsis orientalis C329.2 is a VanA homologue with D-alanyl-D-lactate ligase activity. J. Bacteriol. 180:5792-5795.
19. Neuhaus, F. C. 1967. D-cycloserine and O-carbamyl-D-serine, p. 40-83. In D. Gottlieb and P. L. Shaw (ed.), Antibiotics, mechanisms of action, vol. 1. Springer-Verlag, Heidelberg, Germany.
20. Peteroy, M., A. Severin, F. Zhao, D. Rosner, U. Lopatin, H. Scherman, A. Belanger, B. Harvey, G. F. Hatfull, P. J. Brennan, and N. D. Connell. 2000. Characterization of a Mycobacterium smegmatis mutant that is simultaneously resistant to D-cycloserine and vancomycin. Antimicrob. Agents Chemother. 44:1701-1704.
21. Rastogi, N., K. S. Goh, and H. L. David. 1990. Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob. Agents Chemother. 34:759-764.
22. Reitz, R. H., H. D. Slade, and F. C. Neuhaus. 1967. The biochemical mechanisms of resistance by streptococci to the antibiotics D-cycloserine and O-carbamyl-D-serine. Biochemistry 6:2561-2570.
23. Reyrat, J. M., and D. Kahn. 2001. Mycobacterium smegmatis: an absurd model for tuberculosis? Trends Microbiol. 9:472-474.
24. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
25. Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs, Jr. 1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919.
26. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. J. Jacobs, and B. R. Bloom. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460.
27. Strohl, W. R. 1992. Compilation and analysis of DNA sequences associated with apparent streptomycete promoters. Nucleic Acids Res. 20:961-974.
28. Strych, U., R. L. Penland, M. Jimenez, K. L. Krause, and M. J. Benedik. 2001. Characterization of the alanine racemases from two Mycobacteria. FEMS Microbiol. Lett. 196:93-98.
29. Takiff, H. E., M. Cimino, M. C. Musso, T. Weisbrod, R. Martinez, M. B. Delgado, L. Salazar, B. R. Bloom, and W. R. Jacobs. 1996. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. USA 93:362-366.
30. Timm, J., M. G. Perilli, C. Duez, J. Trias, G. Orefici, L. Fattorini, G. Amicosante, A. Oratore, B. Joris, J. M. Frere, A. P. Pugsley, and B. Gicquel. 1994. Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer. Mol. Microbiol. 12:491-504.
31. Tyagi, J. S., and D. Sharma. 2002. Mycobacterium smegmatis and tuberculosis Trends Microbiol. 10:68-69.
32. Walsh, C. T. 1989. Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly. J. Biol. Chem. 264:2393-2396.
33. Whipple, D. L., R. B. Le Febvre, R. E. Andrews, Jr., and A. B. Thiermann, 1987. Isolation and analysis of restriction endonuclease digestive patterns of chromosomal DNA from Mycobacterium paratuberculosis and other Mycobacterium species. J. Clin. Microbiol. 25:1511-1515.
34. Wijsman, H. J. 1972. The characterization of an alanine racemase mutant of Escherichia coli. Genet. Res. 20:269-277.
35. World Health Organization. 2000. Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB). WHO/DCS/TB/2000.279. World Health Organization, Geneva, Switzerland.
36. Yew, W. W., C. F. Wong, P. C. Wong, J. Lee, and C. H. Chau. 1993. Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin. Clin. Infect. Dis. 17:288-289.
37. Zygmunt, W. A. 1963. Antagonism of D-cycloserine inhibition of mycobacterial growth by D-alanine. J. Bacteriol. 85:1217-1220.